GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Cash From Other Investing Activities

OrbusNeich Medical Group Holdings (FRA:Q8T) Cash From Other Investing Activities : €-9.1 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

OrbusNeich Medical Group Holdings's cash from other investing activities for the six months ended in Jun. 2024 was €3.5 Mil. It means OrbusNeich Medical Group Holdings received €3.5 Mil from other investing activities. OrbusNeich Medical Group Holdings's cash from other investing activities for the trailing twelve months (TTM) ended in Jun. 2024 was €-9.1 Mil.

OrbusNeich Medical Group Holdings Cash From Other Investing Activities Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Cash From Other Investing Activities Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash From Other Investing Activities
0.02 0.01 -2.68 -3.12 2.31

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only -14.10 10.94 2.84 -12.61 3.52

OrbusNeich Medical Group Holdings Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-9.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Cash From Other Investing Activities
Comparable Companies
HKSE:09997 HKSE:06699 HKSE:01501 HKSE:03600 HKSE:02276 HKSE:01942 HKSE:01358 HKSE:01120 HKSE:01406 HKSE:01947 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
06929:Hong Kong
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
Website
https://www.orbusneich.com
OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines